Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
Nat Commun
.
2022 Feb 2;13(1):733.
doi: 10.1038/s41467-022-28393-7.
Authors
Gayatri Amirthalingam
#
1
,
Jamie Lopez Bernal
#
2
,
Nick J Andrews
2
,
Heather Whitaker
3
,
Charlotte Gower
2
,
Julia Stowe
2
,
Elise Tessier
2
,
Sathyavani Subbarao
2
,
Georgina Ireland
2
,
Frances Baawuah
2
4
,
Ezra Linley
5
,
Lenesha Warrener
6
,
Michelle O'Brien
4
,
Corinne Whillock
2
,
Paul Moss
7
,
Shamez N Ladhani
2
8
,
Kevin E Brown
2
,
Mary E Ramsay
2
Affiliations
1
Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom. gayatri.amirthalingam@phe.gov.uk.
2
Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
3
Statistics, Modelling and Economics Department, UK Health Security Agency, London, United Kingdom.
4
Brondesbury Medical Centre, Kilburn, London, United Kingdom.
5
Sero-Epidemiolgy Unit, UK Health Security Agency, Manchester, United Kingdom.
6
Virus Reference Department, UK Health Security Agency, London, United Kingdom.
7
Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, United Kingdom.
8
Paediatric Infectious Diseases Research Group, St. George's University of London, London, United Kingdom.
#
Contributed equally.
PMID:
35110555
PMCID:
PMC8808467
DOI:
10.1038/s41467-022-28393-7
No abstract available
Publication types
Published Erratum